Immunoglobulin A nephropathy (IGAN)
Clinical trials for Immunoglobulin A nephropathy (IGAN) explained in plain language.
Never miss a new study
Get alerted when new Immunoglobulin A nephropathy (IGAN) trials appear
Sign up with your email to follow new studies for Immunoglobulin A nephropathy (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily pill protect kidneys in IgA nephropathy? MRI study puts atrasentan to the test
Disease control Not yet recruitingResearchers are testing whether adding atrasentan to standard supportive care improves kidney structure and function in adults with IgA nephropathy, a condition where the immune system damages the kidneys. About 20 participants will take atrasentan 0.75 mg once daily for 52 weeks…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
Phase 4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Sep 21, 2026 20:00 UTC
-
Can a new biologic slow kidney damage in IgA nephropathy?
Disease control Not yet recruitingThis phase 2 trial is investigating whether an experimental drug called ARGX-121 can improve outcomes for adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either ARGX-121 or a placebo, while continuing their usual care. The …
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
Phase 2 • Sponsor: argenx • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New drug aims to slow kidney damage in IgA nephropathy
Disease control Not yet recruitingThis Phase 2 trial tests an experimental drug called HS-10542 in 90 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either a high dose, low dose, or placebo for a set period. The main goal is to see if the drug reduces prot…
Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY (IGAN)
Phase 2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC